A Braf kinase-inactive mutant induces lung adenocarcinoma
The initiating oncogenic event in almost half of human lung adenocarcinomas is still unknown, complicating the development of selective targeted therapies. Yet these tumours harbour a number of alterations without obvious ...
Aug 3, 2017
0
5